All-cause mortality benefit with ICD use in STEMI patients treated with primary PCI - PACE-CME

Allcause mortality benefit with ICD use in STEMI patients treated with primary PCI

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Hs-troponin measured 30 min after admission to diagnose MI
Hs-troponin measured 30 min after admission to diagnose MI
ESC 2019
Hs-troponin measured 30 min after admission to diagnose MI
- Camilla Bang, MD
Betablocker use associated with reduced mortality in HFrEF patients >80 years
Betablocker use associated with reduced mortality in HFrEF patients >80 years
ESC 2019
Betablocker use associated with reduced mortality in HFrEF patients >80 years
- Gianluigi Savarese, MD
Sex-related differences in ACS patients
Sex-related differences in ACS patients
ESC 2019
Sex-related differences in ACS patients
- Sanne Peters, PhD
NP metabolism associated with clinical outcomes in HF
NP metabolism associated with clinical outcomes in HF
ESC 2019
NP metabolism associated with clinical outcomes in HF
- Frank Gommans, MD, PhD